In  ||| S:0 E:3 ||| IN
vitro  ||| S:3 E:9 ||| JJ
cytotoxicity  ||| S:9 E:22 ||| NN
of  ||| S:22 E:25 ||| IN
metallic  ||| S:25 E:34 ||| NNS
ions  ||| S:34 E:39 ||| VBP
released  ||| S:39 E:48 ||| VBN
from  ||| S:48 E:53 ||| IN
dental  ||| S:53 E:60 ||| JJ
alloys  ||| S:60 E:67 ||| NNS
The  ||| S:67 E:71 ||| DT
cytotoxicity  ||| S:71 E:84 ||| NN
of  ||| S:84 E:87 ||| IN
a  ||| S:87 E:89 ||| DT
dental  ||| S:89 E:96 ||| JJ
alloy  ||| S:96 E:102 ||| NN
depends  ||| S:102 E:110 ||| VBZ
on ||| S:110 E:112 ||| RP
,  ||| S:112 E:114 ||| ,
but  ||| S:114 E:118 ||| CC
is  ||| S:118 E:121 ||| VBZ
not  ||| S:121 E:125 ||| RB
limited  ||| S:125 E:133 ||| VBN
to ||| S:133 E:135 ||| TO
,  ||| S:135 E:137 ||| ,
the  ||| S:137 E:141 ||| DT
extent  ||| S:141 E:148 ||| NN
of  ||| S:148 E:151 ||| IN
its  ||| S:151 E:155 ||| PRP$
corrosion  ||| S:155 E:165 ||| JJ
behavior ||| S:165 E:173 ||| NN
.  ||| S:173 E:175 ||| .
Individual  ||| S:175 E:186 ||| JJ
ions  ||| S:186 E:191 ||| NN
may  ||| S:191 E:195 ||| MD
have  ||| S:195 E:200 ||| VB
effects  ||| S:200 E:208 ||| NNS
on  ||| S:208 E:211 ||| IN
cell  ||| S:211 E:216 ||| NN
viability  ||| S:216 E:226 ||| NN
that  ||| S:226 E:231 ||| WDT
are  ||| S:231 E:235 ||| VBP
different  ||| S:235 E:245 ||| JJ
from  ||| S:245 E:250 ||| IN
metals  ||| S:250 E:257 ||| NNS
interacting  ||| S:257 E:269 ||| VBN
within  ||| S:269 E:276 ||| IN
the  ||| S:276 E:280 ||| DT
alloy  ||| S:280 E:286 ||| JJ
structure ||| S:286 E:295 ||| NN
.  ||| S:295 E:297 ||| .
We  ||| S:297 E:300 ||| PRP
aimed  ||| S:300 E:306 ||| VBD
to  ||| S:306 E:309 ||| TO
investigate  ||| S:309 E:321 ||| VB
the  ||| S:321 E:325 ||| DT
cytotoxicity  ||| S:325 E:338 ||| NN
of  ||| S:338 E:341 ||| IN
individual  ||| S:341 E:352 ||| JJ
metal  ||| S:352 E:358 ||| NN
ions  ||| S:358 E:363 ||| NN
in  ||| S:363 E:366 ||| IN
concentrations  ||| S:366 E:381 ||| JJ
similar  ||| S:381 E:389 ||| JJ
to  ||| S:389 E:392 ||| TO
those  ||| S:392 E:398 ||| DT
reported  ||| S:398 E:407 ||| VBN
to  ||| S:407 E:410 ||| TO
be  ||| S:410 E:413 ||| VB
released  ||| S:413 E:422 ||| VBN
from  ||| S:422 E:427 ||| IN
Pd-based  ||| S:427 E:436 ||| JJ
dental  ||| S:436 E:443 ||| JJ
alloys  ||| S:443 E:450 ||| NNS
on  ||| S:450 E:453 ||| IN
mouse  ||| S:453 E:459 ||| NN
fibroblast  ||| S:459 E:470 ||| NN
cells ||| S:470 E:475 ||| NNS
.  ||| S:475 E:477 ||| .
Metal  ||| S:477 E:483 ||| NN
salts  ||| S:483 E:489 ||| NNS
were  ||| S:489 E:494 ||| VBD
used  ||| S:494 E:499 ||| VBN
to  ||| S:499 E:502 ||| TO
prepare  ||| S:502 E:510 ||| VB
seven  ||| S:510 E:516 ||| CD
solutions  ||| S:516 E:526 ||| NNS
( ||| S:526 E:527 ||| -LRB-
concentration  ||| S:527 E:541 ||| NN
range  ||| S:541 E:547 ||| NN
100 ppm-1 ppb ||| S:547 E:560 ||| CD
)  ||| S:560 E:562 ||| -RRB-
of  ||| S:562 E:565 ||| IN
the  ||| S:565 E:569 ||| DT
transition  ||| S:569 E:580 ||| NN
metals ||| S:580 E:586 ||| NNS
,  ||| S:586 E:588 ||| ,
such  ||| S:588 E:593 ||| JJ
as  ||| S:593 E:596 ||| IN
Ni ||| S:596 E:598 ||| NNP
( ||| S:598 E:599 ||| -LRB-
II ||| S:599 E:601 ||| NNP
) ||| S:601 E:602 ||| -RRB-
,  ||| S:602 E:604 ||| ,
Pd ||| S:604 E:606 ||| NNP
( ||| S:606 E:607 ||| -LRB-
II ||| S:607 E:609 ||| NNP
) ||| S:609 E:610 ||| -RRB-
,  ||| S:610 E:612 ||| ,
Cu ||| S:612 E:614 ||| NNP
( ||| S:614 E:615 ||| -LRB-
II ||| S:615 E:617 ||| NNP
) ||| S:617 E:618 ||| -RRB-
,  ||| S:618 E:620 ||| ,
and  ||| S:620 E:624 ||| CC
Ag ||| S:624 E:626 ||| NNP
( ||| S:626 E:627 ||| -LRB-
I ||| S:627 E:628 ||| PRP
) ||| S:628 E:629 ||| -RRB-
,  ||| S:629 E:631 ||| ,
and  ||| S:631 E:635 ||| CC
the  ||| S:635 E:639 ||| DT
metals ||| S:639 E:645 ||| NNS
,  ||| S:645 E:647 ||| ,
such  ||| S:647 E:652 ||| JJ
as  ||| S:652 E:655 ||| IN
Ga ||| S:655 E:657 ||| NNP
( ||| S:657 E:658 ||| -LRB-
III ||| S:658 E:661 ||| NNP
) ||| S:661 E:662 ||| -RRB-
,  ||| S:662 E:664 ||| ,
In ||| S:664 E:666 ||| IN
( ||| S:666 E:667 ||| -LRB-
III ||| S:667 E:670 ||| NNP
) ||| S:670 E:671 ||| -RRB-
,  ||| S:671 E:673 ||| ,
and  ||| S:673 E:677 ||| CC
Sn ||| S:677 E:679 ||| NNP
( ||| S:679 E:680 ||| -LRB-
II ||| S:680 E:682 ||| NNP
) ||| S:682 E:683 ||| -RRB-
.  ||| S:683 E:685 ||| .
Cytotoxicity  ||| S:685 E:698 ||| NNP
on  ||| S:698 E:701 ||| IN
mouse  ||| S:701 E:707 ||| NN
fibroblasts  ||| S:707 E:719 ||| VBD
L929  ||| S:719 E:724 ||| NNP
was  ||| S:724 E:728 ||| VBD
evaluated  ||| S:728 E:738 ||| VBN
using  ||| S:738 E:744 ||| VBG
the  ||| S:744 E:748 ||| DT
MTT  ||| S:748 E:752 ||| NNP
assay ||| S:752 E:757 ||| NN
.  ||| S:757 E:759 ||| .
Ni ||| S:759 E:761 ||| NNP
,  ||| S:761 E:763 ||| ,
Cu ||| S:763 E:765 ||| NNP
,  ||| S:765 E:767 ||| ,
and  ||| S:767 E:771 ||| CC
Ag  ||| S:771 E:774 ||| NNP
are  ||| S:774 E:778 ||| VBP
cytotoxic  ||| S:778 E:788 ||| VBN
at  ||| S:788 E:791 ||| IN
10 ppm ||| S:791 E:797 ||| NNP
,  ||| S:797 E:799 ||| ,
Pd  ||| S:799 E:802 ||| NNP
and  ||| S:802 E:806 ||| CC
Ga  ||| S:806 E:809 ||| NNP
at  ||| S:809 E:812 ||| IN
100 ppm ||| S:812 E:819 ||| CD
.  ||| S:819 E:821 ||| .
Sn  ||| S:821 E:824 ||| NNP
and  ||| S:824 E:828 ||| CC
In  ||| S:828 E:831 ||| IN
were  ||| S:831 E:836 ||| VBD
not  ||| S:836 E:840 ||| RB
able  ||| S:840 E:845 ||| JJ
to  ||| S:845 E:848 ||| TO
induce  ||| S:848 E:855 ||| VB
cytotoxicity  ||| S:855 E:868 ||| VBN
at  ||| S:868 E:871 ||| IN
the  ||| S:871 E:875 ||| DT
tested  ||| S:875 E:882 ||| JJ
concentrations ||| S:882 E:896 ||| NNS
.  ||| S:896 E:898 ||| .
Transition  ||| S:898 E:909 ||| NN
metals  ||| S:909 E:916 ||| NNS
were  ||| S:916 E:921 ||| VBD
able  ||| S:921 E:926 ||| JJ
to  ||| S:926 E:929 ||| TO
induce  ||| S:929 E:936 ||| VB
cytotoxic  ||| S:936 E:946 ||| JJ
effects  ||| S:946 E:954 ||| NNS
in  ||| S:954 E:957 ||| IN
concentrations  ||| S:957 E:972 ||| JJ
similar  ||| S:972 E:980 ||| JJ
to  ||| S:980 E:983 ||| TO
those  ||| S:983 E:989 ||| DT
reported  ||| S:989 E:998 ||| VBN
to  ||| S:998 E:1001 ||| TO
be  ||| S:1001 E:1004 ||| VB
released  ||| S:1004 E:1013 ||| VBN
from  ||| S:1013 E:1018 ||| IN
Pd-based  ||| S:1018 E:1027 ||| JJ
dental  ||| S:1027 E:1034 ||| JJ
alloys ||| S:1034 E:1040 ||| NNS
.  ||| S:1040 E:1042 ||| .
Ni ||| S:1042 E:1044 ||| NNP
,  ||| S:1044 E:1046 ||| ,
Cu ||| S:1046 E:1048 ||| NNP
,  ||| S:1048 E:1050 ||| ,
and  ||| S:1050 E:1054 ||| CC
Ag  ||| S:1054 E:1057 ||| NNP
were  ||| S:1057 E:1062 ||| VBD
the  ||| S:1062 E:1066 ||| DT
most  ||| S:1066 E:1071 ||| RBS
cytotoxic  ||| S:1071 E:1081 ||| RB
followed  ||| S:1081 E:1090 ||| VBN
by  ||| S:1090 E:1093 ||| IN
Pd  ||| S:1093 E:1096 ||| NNP
and  ||| S:1096 E:1100 ||| CC
Ga ||| S:1100 E:1102 ||| NNP
;  ||| S:1102 E:1104 ||| :
Sn  ||| S:1104 E:1107 ||| NNP
and  ||| S:1107 E:1111 ||| CC
In  ||| S:1111 E:1114 ||| IN
were  ||| S:1114 E:1119 ||| VBD
not  ||| S:1119 E:1123 ||| RB
cytotoxic ||| S:1123 E:1132 ||| VBN
.  ||| S:1132 E:1134 ||| .
Cytotoxic  ||| S:1134 E:1144 ||| JJ
reactions  ||| S:1144 E:1154 ||| NNS
might  ||| S:1154 E:1160 ||| MD
be  ||| S:1160 E:1163 ||| VB
considered  ||| S:1163 E:1174 ||| VBN
in  ||| S:1174 E:1177 ||| IN
the  ||| S:1177 E:1181 ||| DT
etiopathogenesis  ||| S:1181 E:1198 ||| NN
of  ||| S:1198 E:1201 ||| IN
clinically  ||| S:1201 E:1212 ||| NN
observed  ||| S:1212 E:1221 ||| VBD
local  ||| S:1221 E:1227 ||| JJ
adverse  ||| S:1227 E:1235 ||| JJ
reactions ||| S:1235 E:1244 ||| NNS
.  ||| S:1244 E:1246 ||| .
